Form 8-K - Current report:
SEC Accession No. 0001140361-25-018277
Filing Date
2025-05-12
Accepted
2025-05-12 07:55:24
Documents
54
Period of Report
2025-05-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048562_8k.htm   iXBRL 8-K 33760
2 EXHIBIT 99.1 ef20048562_ex99-1.htm EX-99.1 77922
3 EXHIBIT 99.2 ef20048562_ex99-2.htm EX-99.2 25369
7 GRAPHIC ef20048562_ex99-1slide1.jpg GRAPHIC 108892
8 GRAPHIC ef20048562_ex99-1slide2.jpg GRAPHIC 247255
9 GRAPHIC ef20048562_ex99-1slide3.jpg GRAPHIC 147136
10 GRAPHIC ef20048562_ex99-1slide4.jpg GRAPHIC 147346
11 GRAPHIC ef20048562_ex99-1slide5.jpg GRAPHIC 90347
12 GRAPHIC ef20048562_ex99-1slide6.jpg GRAPHIC 163026
13 GRAPHIC ef20048562_ex99-1slide7.jpg GRAPHIC 179461
14 GRAPHIC ef20048562_ex99-1slide8.jpg GRAPHIC 111882
15 GRAPHIC ef20048562_ex99-1slide9.jpg GRAPHIC 214311
16 GRAPHIC ef20048562_ex99-1slide10.jpg GRAPHIC 168689
17 GRAPHIC ef20048562_ex99-1slide11.jpg GRAPHIC 145093
18 GRAPHIC ef20048562_ex99-1slide12.jpg GRAPHIC 138164
19 GRAPHIC ef20048562_ex99-1slide13.jpg GRAPHIC 111135
20 GRAPHIC ef20048562_ex99-1slide14.jpg GRAPHIC 114339
21 GRAPHIC ef20048562_ex99-1slide15.jpg GRAPHIC 127617
22 GRAPHIC ef20048562_ex99-1slide16.jpg GRAPHIC 137405
23 GRAPHIC ef20048562_ex99-1slide17.jpg GRAPHIC 165239
24 GRAPHIC ef20048562_ex99-1slide18.jpg GRAPHIC 165804
25 GRAPHIC ef20048562_ex99-1slide19.jpg GRAPHIC 151273
26 GRAPHIC ef20048562_ex99-1slide20.jpg GRAPHIC 100513
27 GRAPHIC ef20048562_ex99-1slide21.jpg GRAPHIC 121792
28 GRAPHIC ef20048562_ex99-1slide22.jpg GRAPHIC 137414
29 GRAPHIC ef20048562_ex99-1slide23.jpg GRAPHIC 95706
30 GRAPHIC ef20048562_ex99-1slide24.jpg GRAPHIC 155540
31 GRAPHIC ef20048562_ex99-1slide25.jpg GRAPHIC 192529
32 GRAPHIC ef20048562_ex99-1slide26.jpg GRAPHIC 120878
33 GRAPHIC ef20048562_ex99-1slide27.jpg GRAPHIC 91791
34 GRAPHIC ef20048562_ex99-1slide28.jpg GRAPHIC 149639
35 GRAPHIC ef20048562_ex99-1slide29.jpg GRAPHIC 147088
36 GRAPHIC ef20048562_ex99-1slide30.jpg GRAPHIC 142782
37 GRAPHIC ef20048562_ex99-1slide31.jpg GRAPHIC 181595
38 GRAPHIC ef20048562_ex99-1slide32.jpg GRAPHIC 194727
39 GRAPHIC ef20048562_ex99-1slide33.jpg GRAPHIC 131398
40 GRAPHIC ef20048562_ex99-1slide34.jpg GRAPHIC 127481
41 GRAPHIC ef20048562_ex99-1slide35.jpg GRAPHIC 191018
42 GRAPHIC ef20048562_ex99-1slide36.jpg GRAPHIC 179925
43 GRAPHIC ef20048562_ex99-1slide37.jpg GRAPHIC 138456
44 GRAPHIC ef20048562_ex99-1slide38.jpg GRAPHIC 93429
45 image00001.jpg GRAPHIC 5366
  Complete submission text file 0001140361-25-018277.txt   7926767

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA galt-20250512.xsd EX-101.SCH 4018
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20250512_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20250512_pre.xml EX-101.PRE 16068
56 EXTRACTED XBRL INSTANCE DOCUMENT ef20048562_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 25932626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)